FDA clears Nurix Therapeutics, Inc.'s GS-6791 for inflammatory disorders; Nurix earns $5M milestone from Gilead. Click for my ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 ...

IRAK4 plays a critical role in toll-like receptor (TLR) and interleukin-1 family receptor (IL-1R) signaling and has both scaffold and kinase functions, making it an ideal target for disruption by ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical app ...

In Ghana, where traditional medicine complements modern healthcare, an increasing number of women are exploring alternative treatments, including cannabis, for breast cancer symptom management .

RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited ...

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, creating a ...

NLRP3 is a member of a family of proteins known as inflammasome ... which in turn inhibits the production of pro-inflammatory cytokines like interleukin-1 beta and interleukin-18, and has ...

ORLANDO, FLORIDA / ACCESS Newswire / April 11, 2025 / RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on th ...

A new study published in Heliyon has found that people who experienced abuse, neglect, or domestic abuse during childhood ...